Inhibitor Therapeutics, Inc. (OTCMKTS:INTI – Get Free Report) saw a large growth in short interest in the month of February. As of February 28th, there was short interest totalling 53,900 shares, a growth of 36.8% from the February 13th total of 39,400 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average trading volume of 100 shares, the days-to-cover ratio is currently 539.0 days.
Inhibitor Therapeutics Price Performance
Shares of INTI remained flat at $0.07 during mid-day trading on Monday. The stock had a trading volume of 13,727 shares, compared to its average volume of 38,647. Inhibitor Therapeutics has a fifty-two week low of $0.04 and a fifty-two week high of $0.14. The stock’s fifty day moving average price is $0.06 and its 200-day moving average price is $0.07. The stock has a market cap of $12.06 million, a P/E ratio of -7.00 and a beta of -0.55.
About Inhibitor Therapeutics
See Also
- Five stocks we like better than Inhibitor Therapeutics
- 3 Stocks to Consider Buying in October
- Can TikTok Stock Picks Really Make You Rich?
- Top Stocks Investing in 5G Technology
- The “Quality” Rotation: Back to Basics Investing
- How to Calculate Return on Investment (ROI)
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Inhibitor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inhibitor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.